MZEI : Summary for MEDIZONE INTL INC COM USD0.001 - Yahoo Finance

U.S. Markets closed

Medizone International, Inc. (MZEI)


OTC BB - OTC BB Delayed Price. Currency in USD
Add to watchlist
0.11+0.02 (+15.79%)
At close: 3:39PM EDT
People also watch
NPHCMYMXNEPHNIMUMKRS
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close0.09
Open0.10
Bid0.00 x
Ask0.00 x
Day's Range0.09 - 0.11
52 Week Range0.04 - 0.17
Volume599,328
Avg. Volume198,945
Market Cap43.33M
Beta1.31
PE Ratio (TTM)-22.00
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire25 days ago

    Medizone International Announces Agreement Retaining EMA Partners as Advisor and Investment Bank

    KALAMAZOO, Mich., March 1, 2017 /PRNewswire/ -- Medizone International, Inc. (MZEI), the developer of AsepticSure®, the only EPA cleared hospital room disinfection technology that combines ozone and hydrogen peroxide to achieve unprecedented kill rates of bacteria and viral pathogens, announced today that the Company has entered into a definitive agreement with EMA Partners retaining them as the Company's advisor for financing and investment banking matters. "We are very pleased to announce that Medizone International has reached an agreement to have EMA Partners serve as our advisor and investment bank.

  • PR Newswire27 days ago

    Medizone International announces the appointment of a new Chairman and Interim CEO

    Effective March 1, 2017, Edwin Marshall, current Chairman and CEO, will step down from leadership of the Company and will become an advisor to the Chairman through this period of transition. "It has been an honor to lead Medizone International for the last 20 years," commented Ed.

  • PR Newswire3 months ago

    AsepticSure Hospital Disinfection System Expands North American Patent Coverage

    SAN FRANCISCO, Dec. 12, 2016 /PRNewswire/ -- Medizone International, Inc. (The Company) (OTCQB:MZEI)  Following its recently announced EPA approval to enter the US market with its WHO Award winning and ...